Effects of pioglitazone on stearoyl-CoA desaturase in obese Zucker fa/fa rats

Journal of Pharmacological Sciences

Volumn 104, Issue 2, 2007, Pages 137-145

  Toyama, Tomoaki ^a   Kudo, Naomi ^a   Hibino, Yasuhide ^a   Mitsumoto, Atsushi ^b   Nishikawa, Masazumi ^c   Kawashima, Yoichi ^a  

^a JOSAI UNIVERSITY   (Japan)

^b JOSAI INTERNATIONAL UNIVERSITY   (Japan)

^c MIYAGI UNIVERSITY   (Japan)

Author keywords

Oleic acid; Palmitoyl CoA elongase; Pioglitazone; Stearoyl CoA desaturase

Indexed keywords

ACYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; ACYL COENZYME A OXIDASE; CARBOXYLASE; ENZYME; FATTY ACID; MESSENGER RNA; OLEIC ACID; PALMITOYL COENZYME A CHAIN ELONGASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FATTY ACID DESATURATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; NONHUMAN; OBESITY; RAT; SERUM; ZUCKER RAT;

EID: 34250805323     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060997     Document Type: Article

References (32)

1. Staels B, Fruchart JC. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes. 2005;54: 2460-2470.
2. Lapsys NM, Kriketos AD, Lim-Fraser M, Poynten AM, Lowy A, Furler SM, et al. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. J Clin Endocrinol Metab. 2000;85:4293-4297.
3. Gerhold DL, Liu F, Jiang G, Li Z, Xu J, Lu M, et al. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists. Endocrinology. 2002;143:2106-2118.
4. Tachibana K, Kobayashi Y, Tanaka T, Tagami M, Sugiyama A, Katayama T, et al. Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms. Nucl Recept. 2005;3:3.
5. Riserus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB, et al. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. Diabetes. 2005;54:1379-1384.
6. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A. 2002;99:11482-11486.
7. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
8. Oshino N, Imai Y, Sato R. A function of cytochrome b5 in fatty acid desaturation by rat liver microsomes. J Biochem (Tokyo). 1971;69:155-167.
9. Oshino N, Sato R. Stimulation by phenols of the reoxidation microsomal bound cytochrome b5 and its implication to fatty acid desaturation. J Biochem (Tokyo). 1971;69:169-180.
10. Nagi MN, Cook L, Suneja SK, Osei P, Cinti DL. Spectrophotometric assay for the condensing enzyme activity of the microsomal fatty acid chain elongation system. Anal Biochem. 1989;179:251-261.
11. Small GM, Burdett K, Connock MJ. A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. Biochem J. 1985;227:205-210.
12. Zhang J, Chrysis D, Underwood LE. Reduction of hepatic insulin-like growth factor I (IGF-I) messenger ribonucleic acid (mRNA) during fasting is associated with diminished splicing of IGF-I pre-mRNA and decreased stability of cytoplasmic IGF-I mRNA. Endocrinology. 1998;139:4523-4530.
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.
14. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Med Sci. 1959;37:911-917.
15. Jeffcoat R. The biosynthesis of unsaturated fatty acids and its control in mammalian liver. Essays Biochem. 1979;15:1-36.
16. Attie AD, Krauss RM, Gray-Keller MP, Brownlie A, Miyazaki M, Kastelein JJ, et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res. 2002;43:1899-1907.
17. Toyama T, Kudo N, Mitsumoto A, Kawashima Y. Regulation of palmitoyl-CoA chain elongation by clofibric acid in the liver of Zucker fa/ fa rats. Lipids. 2005;40:463-470.
18. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology. 2003;38:1529-1539.
19. Kim H, Haluzik M, Gavrilova O, Yakar S, Portas J, Sun H, et al. Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes. Diabetologia. 2004;47:2215-2225.
20. Montanaro MA, Lombardo YB, Gonzalez MS, Bernasconi AM, Chicco A, Rimoldi OJ, et al. Effect of troglitazone on the desaturases in a rat model of insulin-resistance induced by a sucrose-rich diet. Prostaglandins Leukot Essent Fatty Acids. 2005;72:241-250.
21. Thiede MA, Ozols J, Strittmatter P. Construction and sequence of cDNA for rat liver stearyl coenzyme A desaturase. J Biol Chem. 1986;261:13230-13235.
22. Kaestner KH, Ntambi JM, Kelly TJ Jr, Lane MD. Differentiation-induced gene expression in 3T3-L1 preadipocytes. A second differentially expressed gene encoding stearoyl-CoA desaturase. J Biol Chem. 1989;264:14755-14761.
23. Zheng Y, Prouty SM, Harmon A, Sundberg JP, Stenn KS, Parimoo S. Scd3 - a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics. 2001;71: 182-191.
24. Miyazaki M, Jacobson MJ, Man WC, Cohen P, Asilmaz E, Friedman JM, et al. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors. J Biol Chem. 2003; 278:33904-33911.
25. Miller CW, Ntambi JM. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci U S A. 1996;93:9443-9448.
26. Miyazaki M, Kim YC, Gray-Keller MP, Attie AD, Ntambi JM. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem. 2000;275:30132-30138.
27. Kurebayashi S, Hirose T, Miyashita Y, Kasayama S, Kishimoto T. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. Diabetes. 1997;46:2115-2118.
28. Tabor DE, Kim JB, Spiegelman BM, Edwards PA. Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2. J Biol Chem. 1999;274:20603-20610.
29. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S. The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. Embo J. 1992;11:433-439.
30. Matsuzaka T, Shimano H, Yahagi N, Amemiya-Kudo M, Okazaki H, Tamura Y, et al. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes. 2004;53:560-569.
31. Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J. 2002;366:377-391.
32. Inagaki K, Aki T, Fukuda Y, Kawamoto S, Shigeta S, Ono K, et al. Identification and expression of a rat fatty acid elongase involved in the biosynthesis of C18 fatty acids. Biosci Biotechnol Biochem. 2002;66:613-621.